MARTIN DANIEL C. (Chief Commercial Officer) received a stock award from DECIPHERA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+20.16K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−43.95K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−31.33K
Price / share
—
Trade value
—
% of position
Net shares
−55.12K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | A · Award | +20.16K | — | — | 36.6% | 55.12K | 75.28K |
| Common Stock Direct | 6/11/2024 | D · Disposition | −43.95K | — | — | 58.4% | 75.28K | 31.33K |
| Common Stock Direct | 6/11/2024 | U · U | −31.33K | — | — | New position | 31.33K | 0.00 |
| Total | −55.12K | $0.00 | ||||||
Stock Option (Right to Buy)
Common Stock
62.97K shares
Shares
−62.97K
Strike price
9.23
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
54.67K shares
Shares
−54.67K
Strike price
8.27
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
44.60K shares
Shares
−44.60K
Strike price
15.48
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
38.90K shares
Shares
−38.90K
Strike price
15.92
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock62.97K shares | 6/11/2024 | D · Disposition | −62.97K | 9.23 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock54.67K shares | 6/11/2024 | D · Disposition | −54.67K | 8.27 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock44.60K shares | 6/11/2024 | D · Disposition | −44.60K | 15.48 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock38.90K shares | 6/11/2024 | D · Disposition | −38.90K | 15.92 | — | 0.00 |